RENAISSANCE TECHNOLOGIES LLC
Institutional investor · Portfolio as of Q1 2020
Top Holdings3,401 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
BRISTOL-MYERS SQUIBB CO | 66M | $3.7B | 3.6% | $49.67 | -12.97% | 2 qtrssince 2019-Q4 | Increased 64 |
NOVO-NORDISK A/S-SPONS ADR | 27.9M | $1.7B | 1.6% | $26.02 | +5.35% | 2 qtrssince 2019-Q4 | Increased 54 |
VERTEX PHARMACEUTICALS INC | 6.9M | $1.6B | 1.6% | $218.97 | +5.91% | 2 qtrssince 2019-Q4 | Decreased 0 |
VERISIGN INC | 8.1M | $1.5B | 1.4% | $190.67 | -1.97% | 2 qtrssince 2019-Q4 | Decreased 0 |
BIOGEN IDEC INC | 4.5M | $1.4B | 1.4% | $296.01 | +6.80% | 2 qtrssince 2019-Q4 | Decreased 0 |
ALLERGAN PLC | 7.1M | $1.3B | 1.2% | — | — | 2 qtrssince 2019-Q4 | Increased 67 |
CHIPOTLE MEXICAN GRILL INC | 1.8M | $1.2B | 1.2% | $16.56 | -22.70% | 2 qtrssince 2019-Q4 | Increased 52 |
WALMART INC | 9.8M | $1.1B | 1.1% | $36.47 | -2.82% | 2 qtrssince 2019-Q4 | Increased 55 |
HUMANA INC | 3.5M | $1.1B | 1.1% | $340.21 | -13.03% | 2 qtrssince 2019-Q4 | Increased 60 |
ABBVIE INC | 13.6M | $1B | 1.0% | $67.24 | -12.28% | 2 qtrssince 2019-Q4 | Increased 58 |
GILEAD SCIENCES INC | 12.5M | $936.8M | 0.9% | $51.50 | +18.02% | 2 qtrssince 2019-Q4 | Decreased 0 |
PALO ALTO NETWORKS INC | 5.4M | $888.6M | 0.9% | $38.57 | -28.05% | 2 qtrssince 2019-Q4 | Decreased 0 |
| 6.4M | $883.1M | 0.9% | — | — | 2 qtrssince 2019-Q4 | Increased 48 | |
| 23.1M | $874.4M | 0.8% | — | — | 2 qtrssince 2019-Q4 | Increased 54 | |
MONSTER BEVERAGE CORP | 13.6M | $765.5M | 0.7% | $31.20 | -9.83% | 2 qtrssince 2019-Q4 | Increased 53 |
AMGEN INC | 3.8M | $760.2M | 0.7% | $194.43 | -10.84% | 2 qtrssince 2019-Q4 | Increased 53 |
NOVARTIS AG-SPONSORED ADR | 8.5M | $700.1M | 0.7% | $73.25 | -8.14% | 2 qtrssince 2019-Q4 | Increased 56 |
HERSHEY CO/THE | 5.3M | $696.3M | 0.7% | $126.51 | -4.91% | 2 qtrssince 2019-Q4 | Increased 52 |
| 78.3M | $675.3M | 0.7% | — | — | 2 qtrssince 2019-Q4 | Decreased 0 | |
TARGET CORP | 7M | $651.6M | 0.6% | $100.95 | -23.10% | 2 qtrssince 2019-Q4 | Increased 54 |
RENAISSANCE TECHNOLOGIES LLC manages $103B across 3401 positions as of Q1 2020. Top holdings: BMY (3.6%), NVO (1.6%), VRTX (1.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.
Active quarter - 602 new positions, 670 exits, 1465 increased. Top move: AGN (INCREASED, conviction 67). Portfolio: $103.0B across 3401 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer